Vittarthaa Life Sciences was incorporated in 2016. Vittarthaa’s main objective is to Discover and Develop new therapeutics, products in Pharmaceuticals, Cosmetics, and Nutraceuticals. Vittarthaa’s core strength lies in identifying unmet clinical needs and developing newer drugs/products starting from hit-to-lead generation and optimization using various in-vitro, ex-vivo and in-vivo assay platforms. All research programs are based on an integrated approach towards target-based discovery strategies and phenotypic screening for an endpoint evaluation, focused on innovative Discovery and Development approach for progressing molecules into the market.
With our work experience in diverse scientific and technical approaches on various scientific platforms and programs, this puts us in a unique position to address medical needs and development of the compounds. Our integrated discovery platforms are scientifically efficient which can be easily repeatable, traceable, and quality oriented.